Software - Application
Compare Stocks
2 / 10Stock Comparison
RSKD vs NICE
Revenue, margins, valuation, and 5-year total return — side by side.
Software - Application
RSKD vs NICE — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Software - Application | Software - Application |
| Market Cap | $812M | $5.85B |
| Revenue (TTM) | $345M | $2.95B |
| Net Income (TTM) | $-28M | $612M |
| Gross Margin | 51.5% | 66.4% |
| Operating Margin | -9.8% | 21.9% |
| Forward P/E | 20.5x | 8.8x |
| Total Debt | $25M | $164M |
| Cash & Equiv. | $162M | $379M |
RSKD vs NICE — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jul 21 | May 26 | Return |
|---|---|---|---|
| Riskified Ltd. (RSKD) | 100 | 17.3 | -82.7% |
| NICE Ltd. (NICE) | 100 | 34.8 | -65.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: RSKD vs NICE
Each card shows where this stock fits in a portfolio — not just who wins on paper.
RSKD is the clearest fit if your priority is momentum.
- +2.4% vs NICE's -38.3%
NICE carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 0 yrs, beta 0.72
- Rev growth 7.7%, EPS growth 43.0%, 3Y rev CAGR 10.5%
- 51.7% 10Y total return vs RSKD's -81.7%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 7.7% revenue growth vs RSKD's 5.2% | |
| Value | Lower P/E (8.8x vs 20.5x) | |
| Quality / Margins | 20.8% margin vs RSKD's -8.0% | |
| Stability / Safety | Beta 0.72 vs RSKD's 1.05, lower leverage | |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | +2.4% vs NICE's -38.3% | |
| Efficiency (ROA) | 11.8% ROA vs RSKD's -6.3%, ROIC 13.2% vs -22.2% |
RSKD vs NICE — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
RSKD vs NICE — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
NICE leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
NICE is the larger business by revenue, generating $2.9B annually — 8.5x RSKD's $345M. NICE is the more profitable business, keeping 20.8% of every revenue dollar as net income compared to RSKD's -8.0%.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $345M | $2.9B |
| EBITDAEarnings before interest/tax | -$27M | $845M |
| Net IncomeAfter-tax profit | -$28M | $612M |
| Free Cash FlowCash after capex | $34M | $665M |
| Gross MarginGross profit ÷ Revenue | +51.5% | +66.4% |
| Operating MarginEBIT ÷ Revenue | -9.8% | +21.9% |
| Net MarginNet income ÷ Revenue | -8.0% | +20.8% |
| FCF MarginFCF ÷ Revenue | +9.9% | +22.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | +6.2% | +9.0% |
| EPS Growth (YoY)Latest quarter vs prior year | +2.5% | +56.5% |
Valuation Metrics
NICE leads this category, winning 4 of 5 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $812M | $5.9B |
| Enterprise ValueMkt cap + debt − cash | $675M | $5.6B |
| Trailing P/EPrice ÷ TTM EPS | -26.39x | 10.02x |
| Forward P/EPrice ÷ next-FY EPS est. | 20.47x | 8.85x |
| PEG RatioP/E ÷ EPS growth rate | — | 0.38x |
| EV / EBITDAEnterprise value multiple | — | 6.67x |
| Price / SalesMarket cap ÷ Revenue | 2.36x | 1.99x |
| Price / BookPrice ÷ Book value/share | 2.54x | 1.58x |
| Price / FCFMarket cap ÷ FCF | 24.55x | 8.32x |
Profitability & Efficiency
NICE leads this category, winning 7 of 8 comparable metrics.
Profitability & Efficiency
NICE delivers a 16.4% return on equity — every $100 of shareholder capital generates $16 in annual profit, vs $-8 for RSKD. NICE carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to RSKD's 0.08x. On the Piotroski fundamental quality scale (0–9), NICE scores 7/9 vs RSKD's 5/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -8.4% | +16.4% |
| ROA (TTM)Return on assets | -6.3% | +11.8% |
| ROICReturn on invested capital | -22.2% | +13.2% |
| ROCEReturn on capital employed | -7.6% | +16.1% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 7 |
| Debt / EquityFinancial leverage | 0.08x | 0.04x |
| Net DebtTotal debt minus cash | -$137M | -$216M |
| Cash & Equiv.Liquid assets | $162M | $379M |
| Total DebtShort + long-term debt | $25M | $164M |
| Interest CoverageEBIT ÷ Interest expense | — | — |
Total Returns (Dividends Reinvested)
RSKD leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in NICE five years ago would be worth $4,175 today (with dividends reinvested), compared to $1,827 for RSKD. Over the past 12 months, RSKD leads with a +2.4% total return vs NICE's -38.3%. The 3-year compound annual growth rate (CAGR) favors RSKD at 0.2% vs NICE's -19.9% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -1.2% | -13.5% |
| 1-Year ReturnPast 12 months | +2.4% | -38.3% |
| 3-Year ReturnCumulative with dividends | +0.6% | -48.6% |
| 5-Year ReturnCumulative with dividends | -81.7% | -58.2% |
| 10-Year ReturnCumulative with dividends | -81.7% | +51.7% |
| CAGR (3Y)Annualised 3-year return | +0.2% | -19.9% |
Risk & Volatility
Evenly matched — RSKD and NICE each lead in 1 of 2 comparable metrics.
Risk & Volatility
NICE is the less volatile stock with a 0.72 beta — it tends to amplify market swings less than RSKD's 1.05 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. RSKD currently trades 83.6% from its 52-week high vs NICE's 53.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.05x | 0.72x |
| 52-Week HighHighest price in past year | $5.68 | $180.61 |
| 52-Week LowLowest price in past year | $3.70 | $94.89 |
| % of 52W HighCurrent price vs 52-week peak | +83.6% | +53.6% |
| RSI (14)Momentum oscillator 0–100 | 68.0 | 71.1 |
| Avg Volume (50D)Average daily shares traded | 766K | 626K |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Wall Street rates RSKD as "Buy" and NICE as "Buy". Consensus price targets imply 55.8% upside for NICE (target: $151) vs 21.1% for RSKD (target: $6).
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $5.75 | $150.88 |
| # AnalystsCovering analysts | 11 | 23 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | — | 0 |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +13.1% | +8.4% |
NICE leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). RSKD leads in 1 (Total Returns). 1 tied.
RSKD vs NICE: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is RSKD or NICE a better buy right now?
For growth investors, NICE Ltd.
(NICE) is the stronger pick with 7. 7% revenue growth year-over-year, versus 5. 2% for Riskified Ltd. (RSKD). NICE Ltd. (NICE) offers the better valuation at 10. 0x trailing P/E (8. 8x forward), making it the more compelling value choice. Analysts rate Riskified Ltd. (RSKD) a "Buy" — based on 11 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — RSKD or NICE?
On forward P/E, NICE Ltd.
is actually cheaper at 8. 8x.
03Which is the better long-term investment — RSKD or NICE?
Over the past 5 years, NICE Ltd.
(NICE) delivered a total return of -58. 2%, compared to -81. 7% for Riskified Ltd. (RSKD). Over 10 years, the gap is even starker: NICE returned +51. 7% versus RSKD's -81. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — RSKD or NICE?
By beta (market sensitivity over 5 years), NICE Ltd.
(NICE) is the lower-risk stock at 0. 72β versus Riskified Ltd. 's 1. 05β — meaning RSKD is approximately 45% more volatile than NICE relative to the S&P 500. On balance sheet safety, NICE Ltd. (NICE) carries a lower debt/equity ratio of 4% versus 8% for Riskified Ltd. — giving it more financial flexibility in a downturn.
05Which is growing faster — RSKD or NICE?
By revenue growth (latest reported year), NICE Ltd.
(NICE) is pulling ahead at 7. 7% versus 5. 2% for Riskified Ltd. (RSKD). On earnings-per-share growth, the picture is similar: NICE Ltd. grew EPS 43. 0% year-over-year, compared to 10. 0% for Riskified Ltd.. Over a 3-year CAGR, NICE leads at 10. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — RSKD or NICE?
NICE Ltd.
(NICE) is the more profitable company, earning 20. 8% net margin versus -8. 0% for Riskified Ltd. — meaning it keeps 20. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NICE leads at 21. 9% versus -8. 4% for RSKD. At the gross margin level — before operating expenses — NICE leads at 66. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is RSKD or NICE more undervalued right now?
On forward earnings alone, NICE Ltd.
(NICE) trades at 8. 8x forward P/E versus 20. 5x for Riskified Ltd. — 11. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for NICE: 55. 8% to $150. 88.
08Which pays a better dividend — RSKD or NICE?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is RSKD or NICE better for a retirement portfolio?
For long-horizon retirement investors, NICE Ltd.
(NICE) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 72)). Both have compounded well over 10 years (NICE: +51. 7%, RSKD: -81. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between RSKD and NICE?
Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: RSKD is a small-cap quality compounder stock; NICE is a small-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.
Compare NICE vs FIVN
FIVN is one of the most direct listed alternatives to NICE.
Compare RSKD vs FICO
FICO overlaps with RSKD in an adjacent operating segment worth comparing.
Expand With AMZN + FIVN
AMZN and FIVN are the strongest missing peers across the current compare set.